{"id":"W4200179740","doi":"10.2147/cpaa.s288842","title":"Pharmacological Profile of Viltolarsen for the Treatment of Duchenne Muscular Dystrophy: A Japanese Experience","year":2021,"lang":"en","type":"review","venue":"Clinical Pharmacology Advances and Applications","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research; Muscular Dystrophy Canada; Alberta Innovates; Alberta Innovates - Health Solutions; Women and Children's Health Research Institute; Children's Health Research Institute","keywords":"Duchenne muscular dystrophy; Exon skipping; Dystrophin; Medicine; Muscular dystrophy; Muscle disorder; Clinical trial; Exon; Bioinformatics; Internal medicine; Genetics; Gene; Biology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001430602,0.000249036,0.001013381,0.00002108596,0.0001309889,0.00000317266,0.0002848553,0.0003208375,0.00006387143],"category_scores_gemma":[0.00004722611,0.0001581667,0.0006007505,0.0001145547,0.0009333578,0.000004132194,0.00008467093,0.0001283835,0.000001369032],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000007031771,"about_ca_system_score_gemma":0.0001274946,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002315501,"about_ca_topic_score_gemma":0.000001422059,"domain_scores_codex":[0.9982761,0.000205004,0.0007178165,0.0005580674,0.00004717223,0.0001958496],"domain_scores_gemma":[0.9983219,0.0006987283,0.0004727736,0.0003040384,0.0001232592,0.00007930955],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002024803,0.00175161,0.00002286278,0.001985167,0.001151254,0.000001139444,0.00004312801,0.00002525121,0.002955311,0.0001672445,0.0006729423,0.9910216],"study_design_scores_gemma":[0.0007828715,0.000813028,0.00001155381,0.00005380312,0.00131806,0.00000458725,0.00008626099,0.00001580699,0.0005394032,0.00003550585,0.9961908,0.0001482967],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002991754,0.9937225,0.0005968115,0.00004673659,0.0002458869,0.002123613,0.0002358516,0.000005841061,0.00003098],"genre_scores_gemma":[0.001916384,0.9911458,0.0004073097,0.00009690864,0.000572725,0.005450081,0.0003088297,0.00001686843,0.00008512152],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9955179,"threshold_uncertainty_score":0.644985,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0735950491683823,"score_gpt":0.4762422176833558,"score_spread":0.4026471685149735,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}